Categories
Event Recap News Obesity Research Incubator Session

3rd Annual Obesity Research Incubator Session

May 15, 2013 – 4PM – 6PM, Bornstein Amphitheatre and Cabot Atrium

The Cardiovascular, Diabetes and Metabolic Disorders Research Center at the Brigham Research Institute considers obesity to be a top research priority in accordance with the recent National Institutes of Health Strategic Plan for Obesity Research. The goal of this session is to bring together obesity and obesity-related comorbidities, to promote cross-collaborative research efforts, and to stimulate new ideas for further investigation as well as to address this challenge public health crisis through research.

With the goal of promoting vibrant scientific discussions, Gail Adler, MD, PhD, introduced the event, the first hour featured oral presentations on a few select themes in obesity research in the Bornstein Amphitheatre, and the second hour offered an interactive poster session on obesity research in the nearby Cabot Atrium.

Speakers

Targeting Start Domains in the Metabolic System

David E. Cohen, MD, PhD, Director of the Massachusetts General Hospital Weight Center and the Obesity Research Center at MGH, Robert H. Ebert Professor of Medicine and Health Sciences and Technology, Harvard Medical School

Gastrointestinal Regulation of Metabolic Function – Insights from Bariatric Surgery

Lee M. Kaplan, MD, PhD, Director of Hepatology, Brigham and Women’s Hospital, Associate Professor of Medicine, Harvard Medical School

Categories
Call for Abstracts Cardiovascular, Diabetes and Metabolic Disorders Poster Sessions

Obesity Incubator Session Call for Abstracts

Categories
Discover Brigham Event Recap News

Highlights from Discover Brigham 2020

Thursday, November 12, 2019 11:00am – 4pm, Virtual Event

Discover Brigham was held virtually this year, the research, innovation and science at the Brigham was brought to life digitally by those who presented their captivating sessions, demos and posters.

Advancing science has never been more critical or time-sensitive as it is right now, given the global pandemic, but it has also never been so inspiring. Our researchers and scientists work every day to change and uplift the global conditions that have impacted our lives. In this year’s Discover Brigham, we came together to create an event that echoed the many strong voices heard around the world calling for change and progress.

On November 12th, the Brigham Research Institute hosted six exciting sessions, nine live demonstrations and featured close to 100 scientific posters at the poster session.

Agenda: Posters, Sessions & Demos

  • Poster Session & Demos
  • Rock the Mic: Postdoc Fast Pitch
  • What We Know About COVID-19
  • Hey Briggie: The use of Artificial Intelligence to Improve Patient Safety and Experience
  • Committing to Diversity, Inclusion and Equity in Clinical Research: The Time is Now
  • Getting Ahead: Advances in Food and Drug Allergy
  • What’s Sex Got To Do With It? Risk and Management of Autoimmune Disease
Ann Wooley, MD highlights the Brigham’s role in the COVID-19 Pandemic

Awards and Prize Winners

One of the sessions held at Discover Brigham was the exciting Postdoc Fast Pitch, during which four brave postdoctoral fellows pitched their projects to an audience. The $1,000 prize was decided by audience vote and the recipient of this prize was Jessica Williams, BS, MSc, PhD, a research fellow in Surgery and Cardiac Surgery who won with her project, “The Effect of Artery Shape on Patient Risk.”

Discover Brigham in the Media

This year, we were thrilled to see attendees from The Boston Globe, WBUR, Boston Herald, STAT News, and USA Today. The Boston Herald published an article highlighting the event, which was also featured on Channel 7 News.

Categories
Events Funding News

Shark Tank Awards Two Researchers

Congratulations to the Winners of the McGraw Family Opioid Awards!

[vc_empty_space]

1st Place: $50,000

Christopher Connor, MD, PhD

Assistant Professor, Anesthesiology

Project: Imaging opioid effects, tolerance and addition in C. elegans

 

2nd Place: $25,000

William Renthal, MD, PhD

Assistant Professor, Neurology

Project: Targeted gene therapy for Chronic Pain

[vc_empty_space]

Featured Image:

Top Left: Scott Weiner, MD, MPH

Top Right: Captain Robert McGraw

Bottom Left: William Renthal, MD, PhD

Bottom Right: Christopher Connor, MD, PhD

[vc_empty_space]

Background on the Event:

Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.

This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine were awarded.

[vc_empty_space]

 

Categories
Events Funding News

McGraw Opioid Innovator Award | Shark Tank Fall 2020

You’re Invited:

[vc_empty_space]

Tuesday, October 20, 4:00 – 5:30pm, Zoom

Click Here to Register

[vc_empty_space]

Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.

This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine will be awarded.

Please note that this event is exclusively for Brigham and Women’s Hospital Staff and Mass General Brigham affiliates.

For more information, please contact bwhbri@partners.org

[vc_empty_space]

 

Categories
Events Funding News

McGraw Family Opioid Innovator Awards | Fall 2020

We are excited to announce that Brigham & Women’s Hospital will host a Shark Tank event in Oct 2020 to fund two innovative and high-risk/high- impact projects in the basic, clinical, digital and translational realms through the McGraw Family Innovator Awards (open to opioid-related research).

Letter of Intent Due: Wednesday, July 22, 2020 | Click here to apply

RFA Due: Friday, September 11, 2020 | Click here for RFA details

[vc_empty_space]
Scope: With the generous support of the McGraw Family, this year’s RFA will focus on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives a year for the past 3 years in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including but not limited to research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine etc. are welcome. Special focus on COVID-19 related research and racial and ethnic disparities research is also welcome.
[vc_empty_space]

Awards: Up to two non-renewable grants will be awarded on a competitive basis with award denominations of up to $50,000 and $25,000 respectively.

[vc_empty_space]
For more information, please contact:
Gloria Brand, MPA, Senior Program Manager
Program in Opioid and Pain Innovation
BWH
617-278-0516
gbrand@bwh.harvard.edu
Categories
Brigham Research Institute Events News

Research Roundtables: Call for Participants

 

RESEARCH ROUNDTABLES | DIALOGUES AND DISCUSSIONS

Calling all members of the research community!

The Brigham Research Institute (BRI) would like to hear what topics are of interest to the research community for our next series of Research Roundtables. Based in the results of the survey below, we will schedule meetings on topics with broad interest.

All members of the research community are encouraged to participate. Please click here to quickly indicate the research topics in which you have interest.

As a grassroots organization, the BRI wants to hear from you as we set goals, create resources and prioritize efforts to best support the community. Please join us to share ideas, discuss needs, identify emerging trends and brainstorm ways to respond to them.

Click here to learn more about these roundtables and how you can benefit from them!

Take the Survey Now!

Categories
Event Recap News

Congratulations Shark Tank Winners!

Athena Petrides, PhD and Joji Suzuki, MD were named the two winners of the McGraw Family Opioid Innovator Award. Out of the five projects pitched, Petrides and Suzuki were voted the winners, each receiving $50,000 to advance their work.

Since 2012, Brigham & Women’s Hospital has been hosting shark tanks to fund innovative and high-risk/high impact projects in the basic, clinical, digital and translational realms through its Health & Technology Innovation Awards. Sponsored by the Brigham Research Institute (BRI) and the BWH Health & Technology Subcommittee, these awards aim to advance projects that have the potential to make an impact in one or more of the following domains – biomedical research, healthcare delivery, the generation of new companies/products/services, cost savings, care quality and provider burnout. Since 2012, more than $1 million has been distributed to BWH investigators through these awards.

This year, with the generous support of the McGraw Family, this cycle’s Request for Applications includes a special track focused on advancing innovations related to solving the opioid crisis which has resulted in the loss of over 2000 lives in the past year in Massachusetts alone. Novel ideas that seek to address questions and challenges related to the opioid epidemic including, but not limited to, research on addiction, adverse effects, alternate pain management strategies, genetic susceptibility to opioid abuse, new tools for opioid research, diagnosis/treatment, management of infectious diseases related to opioid abuse, withdrawal, personalized medicine will be awarded.

Shark Tank Winner

Athena Petrides, PhD, Assistant Professor, Pathology, BWH

DigiToxRX: Treating Pain is No Longer Painful

Interpreting urine toxicology results is a time-consuming and complex task for clinicians prescribing opioids. Approximately 500 toxicology results are misinterpreted annually at Brigham and Women’s Hospital, potentially leading to inappropriate opioid refills and discontinuation of appropriate opioid treatment. DigiToxRx offers a complete solution, which encompasses a novel testing methodology paired with software that automates personalized toxicology interpretations. Our recent study demonstrated that personalized interpretations improved clinician confidence in result review by 34% and increased the speed of review by 46%. Financial support of DigiToxRx will allow us to automate personalized interpretations and to scale this service across Partners and potentially other healthcare systems.

Shark Tank Winner

Joji Suzuki, MD, Assistant Professor, Psychiatry, BWH

Pilot Study of cannabidiol (CBD) for the treatment of opioid use disorder

Research has shown that buprenorphine (suboxone) reduces the risk of overdose among individuals with opioid use disorder (OUD) by up to 70%. However, 50% of patients will leave treatment in the first 6 months, partly due to the emergence of strong cravings in response to cues. Recent animal and human studies demonstrate that cannabidiol (CBD), a non-addictive constituent of marijuana, helps to blunt the cravings that emerge after exposure to cues. Our team propose to conduct a pilot study to determine if CBD will reduce cue-induced cravings among OUD patients currently taking buprenorphine. If successful, this study will lay the groundwork for a NIH-funded study to conduct a series of human trials with CBD for OUD patients as an adjunct to buprenorphine treatment.

Other Finalists

Peter Chai, MD, MMS, Assistant Professor, Emergency Medicine, BWH

Enabling smart sewers to measure community level opioid and naloxone consumption

Christopher W. Connor, MD, PhD, Assistant Professor, Anesthesiology, BWH

Imaging opioid effects, tolerance and addiction in C. elegans

R. Jason Yong, MD, MBA, Instructor, Anesthesiology, BWH

Smart Pill Dispenser to Enhance Opioid Compliance and Patient Outcomes

Categories
Events News

2020 – 2021 Guest ROC Slots Available

The BRI Executive Committee is opening three guest slots at each monthly Research Oversight Committee (ROC) meeting. If you wish to attend a ROC meeting, please sign up here (note that you may only attend one ROC meeting per calendar year as a guest). Feel free to email bwhbri@partners.org with questions.

The BRI’s overarching mission is to accelerate discoveries that improve human health; supporting strategies include fostering groundbreaking, interdepartmental, and interdisciplinary research, ranging from basic fundamental studies to clinical innovations. We strive to provide a clear voice (internally and externally) for the entire BWH research community, raise the profile of research at BWH, develop mission-centric collaborations with external entities and engage the scientific community in fundraising. Research Oversight Committee (ROC) members help bring forward the needs and concerns of their colleagues; accordingly, the composition of the ROC is intended to collectively reflect the diversity of the BWH research community.

Categories
Events News

Help us Celebrate National Postdoc Appreciation Week!

Join the PostDoctoral Association from September 16 to September 20 to recognize all that our postdocs do for the research community at BWH and across the nation.

TACO PARTY

Monday, September 16 | 5 – 7 pm | Marshall A. Wolf Conference Room | Registration

 

PLC MEET AND GREET

Tuesday, September 17 | 11:30 am – 1 pm | Miller Atrium on the Pike

 

JOINT SOCIAL WITH HMS

Wednesday, September 18 | 5 – 7 pm | NRB 10th floor | Registration to come

 

ICE CREAM SOCIAL

Friday, September 20 | 1 – 3 pm | Marshall A. Wolf Conference Room | Registration